Abstract
Rationale: Management of cow’s milk allergy (CMA) presents a significant burden on the health care system. A healthy gut microbiota is important for the prognosis of CMA and synbiotic use may correct gut dysbiosis, improve clinical outcomes and reduce healthcare use.1,2 This study evaluated the impact of a synbiotic-containing (galacto-oligosaccharides, fructo-oligosaccharides, Bifidobacterium breve M-16V) whey-based, extensively hydrolysed formula (SeHF), on healthcare use of infants with CMA.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
